｜國際事務 International Affairs｜
強化台日半導體合作：與東北大學更新合作備忘錄
Strengthening Taiwan-Japan Semiconductor Collaboration: Tohoku University Renews 20-Year Partnership with NYCU
日本東北大學(Tohoku University)訪問團上週造訪陽明交通大學，重新更新合作備忘錄，深化台日兩所半導體第一頂尖大學近20年的合作關係。
陽明交大與東北大學自2005年締結合作以來，已建立多層次的交流結盟。此次在國家發展委員會詹方冠副主委、宏碁共同創辦人邰中和董事長、前思源基金會林嘉勳董事長等人見證下完成新的合作備忘錄，內容涵蓋師生交流、雙聯學位、共同研究實驗室設立及產學共創計畫推進等領域，還特別加入共同推動「台日共同基金」的許諾，兩校致力以科學發展與創新產業實際推動為核心，構建「以大學為基礎的跨國共創平台」，為亞洲目前所具有的半導體優勢，提供持續進步的關鍵動能。
Last week, a delegation from Tohoku University visited National Yang Ming Chiao Tung University (NYCU) to renew the Memorandum of Understanding (MoU), reinforcing nearly two decades of collaboration between Taiwan and Japan’s leading semiconductor universities.
Since establishing our partnership in 2005, NYCU and Tohoku University have built a multi-faceted alliance. The renewed MoU, signed in the presence of Deputy Minister Fang-Guan Jan of the National Development Council (NDC), Acer co-founder Ken Tai, and former Chairman of the Spring Foundation at NCTU, Chia-Shin Lin, encompasses faculty and student exchanges, dual degree programs, joint research laboratories, and industry-academia initiatives.
Notably, the agreement includes a commitment to launch a “Taiwan-Japan Joint Fund,” which fosters a university-based transnational co-creation platform centered on scientific advancement and industrial innovation. This platform will provide vital momentum to sustain Asia’s semiconductor leadership.
｜研究亮點 Research Highlights｜
藥理所黃自強教授破解致病蛋白結構：助囊性纖維化、腹瀉等疾病藥物開發
Professor Tzyh-Chang Hwang Deciphers Pathogenic Protein Structure, Advancing Drug Development for Cystic Fibrosis and Diarrheal Diseases
同樣的藥、相同的基因，為什麼對人有效、對豬無效？陽明交大藥理學研究所教授黃自強藉由解析囊性纖維化（cystic fibrosis）致病蛋白的結構，發現藥物能改變該蛋白的構造，了解微小結構差異，如何影響藥物的效果，這一突破性成果將為囊性纖維化、腹瀉等疾病帶來全新一代的治療藥物。
Why do drugs work in humans but not in pigs, even when the same genes are involved? A groundbreaking study by Professor Tzyh-Chang Hwang from NYCU has revealed the structural intricacies of the cystic fibrosis (CF) protein, providing insights into how minor structural variations influence drug efficacy. This discovery could pave the way for a new generation of treatments for cystic fibrosis, diarrheal diseases, and beyond.
｜榮譽 Honor｜
雷射系統研究中心獲國家人才發展獎 展現科技人才培育創新實力！
NYCU LSRC Wins National Talent Development Award’s Outstanding Case Award, Showcasing Innovation in Tech Talent Cultivation
被譽為企業界人才發展的「奧斯卡金像獎」——國家人才發展獎，是國內人力資源領域的最高榮譽。今年，陽明交大雷射系統研究中心經由勞動力發展署桃竹苗分署推薦，成功奪下「傑出個案獎」，展現其在科技人才培育上的非凡成就。
The National Talent Development Award hailed as the “Oscar of Talent Development” in the corporate world, is the highest honor in Taiwan’s human resources sector. This year, the Laser System Research Center (LSRC) at NYCU, recommended by the Taoyuan-Hsinchu-Miaoli Branch of the Workforce Development Agency, claimed the Outstanding Case Award, highlighting its exceptional achievements in nurturing technological talent.